General Surgical Innovations forms cardiovascular distribution deals:
This article was originally published in Clinica
Executive Summary
General Surgical Innovations has signed exclusive distribution agreements for its range of cardiovascular products in the UK, Germany, Belgium, Holland, Italy, Portugal, Spain. The agreements with unnamed distributors include its Endosaph system for the minimally-invasive harvesting of the saphenous vein and the surgical balloon dissector for subfascial endoscopic perforator surgery. The company has a direct sales force in the US and sells in Japan through an exclusive distribution agreement.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.